This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Novel Gamma-Delta (γδ)T Cell Therapy for Treatment of Patients With Newly Diagnosed Glioblastoma (DRI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04165941
Recruitment Status : Active, not recruiting
First Posted : November 18, 2019
Last Update Posted : January 24, 2024
Sponsor:
Collaborator:
In8bio Inc.
Information provided by (Responsible Party):
Louis Burt Nabors, MD, University of Alabama at Birmingham

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 31, 2024
Estimated Study Completion Date : December 31, 2024